Merck & Co

Pharmaceuticals
MRK
$ 103 (1.3)%
Share price
$ 261 bn
Market Cap
$ 295 bn
Enterprise Value

Carbon footprint

3.1 Ton
GHG emissions per $ 1 mln investment
0.09x the weighted average for S&P 500
FY2021
How is this calculated?
-1.8%
YOY change in GHG emissions
Stronger than the -0.8% weighted average for S&P 500
FY2021 vs. previous year

Primary Climate Goal

-25%
Proj. YOY change in GHG emissions (Scope 1 + 2)
Stronger than the -8% weighted average for S&P 500
FY2022
How is this calculated?

Merck & Co aims to achieve carbon neutrality for Scope 1 + 2 by 2025


This target has not been verified as science based according to SBTi
Merck & Co's actual and proj. GHG emissions (Scope 1 + 2) (Kt of CO2e)

Secondary Climate Goal

-4%
Proj. YOY change in GHG emissions (Scope 3)
Weaker than the -6.2% weighted average for S&P 500
FY2022
How is this calculated?

Merck & Co aims to reduce Scope 3 by 30% by 2030 from a base year 2019


1.5°C
Merck & Co's actual and proj. GHG emissions (Scope 3) (Kt of CO2e)

GHG emissions and Carbon intensity

Merck & Co's GHG emissions (market-based) (Kt of CO2e)
Merck & Co's Carbon intensity (Tons per 1 USDm)

Merck & Co's carbon footprint

Merck & Co reported Total CO2e Emissions - Market-Based Scope 1 + Scope 2 for the twelve months ending 31 December 2021 at 926 Kt (-17 /-1.8% y-o-y). Also positively, carbon intensity was down at 19 t (-3.7 /-16.3% y-o-y).

Merck & Co's Scope 3 emissions was up at 6,959 Kt (+501/+7.8% y-o-y). This is a higher growth rate than over the period since 4Q'15 (+3.2% CAGR).

The company is committed to achieving carbon neutrality for Scope 1 + 2 by 2025, which translates into the estimated reduction of -231 Kt per annum over the period of FY2022 - FY2025. This target, however, has not been recognised as science-based (and as aligned with Paris Agreement) by the SBTi.

Also, the company commits to reducing Scope 3 by 30% by 2030 from a base year 2019, which translates into the estimated reduction of -277 Kt per annum over the period of FY2022 - FY2030. This science-based target is aligned with Paris Agreement to limit global warming to 1.5°C above pre-industrial levels.

Merck & Co aims to achive carbon neutrality across its operations (Scope 1 + 2) in 2025. Companies normally become carbon neutral with the help of the acquisition of carbon offsets rather than absolute reductions in their own greenhouse emissions. Also, carbon neutrality does not include non-CO2 GHG emissions.

Company environmental metrics

Show more...